Pharma Marketing Network Home

John Mack

Pharma Marketing Blog represents the opinions of
John Mack
Publisher of
Pharma Marketing News.



We accept advertising relevant to the interests of our members.
For more information, see:

Media Kit





Operated by:
VirSci Corporation
PO Box 760
Newtown, PA 18940
215-504-4164
215-504-5739 (FAX)
E-mail: infovirsci@virsci.com
Pharma Marketing Blog


My Humble Opinion
Pharma Marketing Blog
Other People's Opinion
Pharma Marketing Talk
A "Must Read" Blog for Insiders. -- Wall Street Journal A bi-weekly podcast. Listen and call-in live online or download to your iPod!

| Also see Pharma Marketing News OpEd Pieces |

Glaxo, Pull Your Imus Ads!

Posted: April 11, 2007

The Wall Street Journal reports that several advertisers, including Pocter & Gamble, announced that are pulling their ad support of the Imus radio show. GlaxoSmithKline is another pharmaceutical company whose ads run on the Imus show.

Glaxo should pull its support and make a strong public statement about it. Not only is this the right thing to do, but it is good marketing considering that the company just applied for U.S. approval of its Cervarix vaccine to prevent cervical cancer.

What do you think? Read more about this and take our quick poll in today's post to Pharma Marketing Blog.

For more posts in related topic areas, see:

If you wish to receive notice by email whenever a post is made to Pharma Marketing Blog, please subscribe.

Enter your Email Address

| Return to Pharma Marketing Blog Topics |

Special Supplement
Direct-to-Consumer Advertising
Volume Two: DTC in the New Era

DTC Vol 2 Supplement Cover
DTC advertising is set for major changes in light of public criticism, but also in reaction to the changing reality of the marketplace where there is less need for a one size fits all solution. DTC must evolve and marketers must pay more attention to measuring and improving its effectiveness. Otherwise, billions of dollars will continue to be wasted. This volume is devoted to DTC best practices with a focus on techniques for improving DTC efficacy and return on investment, which is generally considered to be declining.

TABLE OF CONTENTS

Order both Volume One and Volume Two and SAVE! (Click Here)

Order and pay for Volume Two now using your credit card.

ONLY $29.95
PDF file delivered to you by email (usually within minutes of placing your order):

If you wish to be pay by check or credit card off-line, please use:
Printable Order Form


Pharma Marketing News | Subscribe | Discussion Forums | Pharma Marketing Roundtable
Reports | Resources/Links | Glossary | Case Studies | Surveys | Pharma Marketing Blog
Pharma Marketing Vendor Directory | Conference Calendar | Pharma Jobs
Advertising Information | FAQs | About Us | Privacy Policy

© 2007. VirSci Corporation. All rights reserved.